159 related articles for article (PubMed ID: 33414415)
1. CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer.
Kim JY; Kim HJ; Jung CW; Lee TS; Kim EH; Park MJ
Cell Death Dis; 2021 Jan; 12(1):48. PubMed ID: 33414415
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
6. RIP1 Is a Novel Component of γ-ionizing Radiation-Induced Invasion of Non-Small Cell Lung Cancer Cells.
Kang AR; Cho JH; Lee NG; Song JY; Hwang SG; Lee DH; Um HD; Park JK
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605153
[No Abstract] [Full Text] [Related]
7. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
9. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3.
Oh SB; Hwang CJ; Song SY; Jung YY; Yun HM; Sok CH; Sung HC; Yi JM; Park DH; Ham YW; Han SB; Hwang BY; Hong JT
Cancer Lett; 2014 Oct; 353(1):95-103. PubMed ID: 25083589
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
16. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 Accelerates Osteoclastogenesis Induced by Non-Small Cell Lung Carcinoma Cells Through Self-Potentiation and VCAM1 Secretion.
Liao T; Chen W; Sun J; Zhang Y; Hu X; Yang S; Qiu H; Li S; Chu T
Cell Physiol Biochem; 2018; 50(3):1084-1099. PubMed ID: 30355915
[TBL] [Abstract][Full Text] [Related]
18. MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.
Wang M; Meng B; Liu Y; Yu J; Chen Q; Liu Y
Cell Physiol Biochem; 2017; 44(5):2017-2028. PubMed ID: 29237164
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
